ALHEMO Trademark

Trademark Overview

On Friday, April 26, 2019, a trademark application was filed for ALHEMO with the United States Patent and Trademark Office. The USPTO has given the ALHEMO trademark a serial number of 79262552. The federal status of this trademark filing is SECTION 71 ACCEPTED as of Friday, April 24, 2026. This trademark is owned by Novo Nordisk Health Care AG. The ALHEMO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for haemostasis
alhemo

General Information

Serial Number79262552
Word MarkALHEMO
Filing DateFriday, April 26, 2019
Status706 - SECTION 71 ACCEPTED
Status DateFriday, April 24, 2026
Registration Number5947017
Registration DateTuesday, December 31, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 15, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations for haemostasis
Translation of Words in MarkThe wording "ALHEMO" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, July 15, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovo Nordisk Health Care AG
Party Type30 - Original Registrant
Legal Entity Type25 - NOT AVAILABLE
AddressZürich CH-8058
CH
Party NameNovo Nordisk Health Care AG
Party Type20 - Owner at Publication
Legal Entity Type25 - NOT AVAILABLE
AddressCH
Party NameNovo Nordisk Health Care AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Trademark Events

Event DateEvent Description
Thursday, July 11, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, July 15, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, July 15, 2019ASSIGNED TO EXAMINER
Friday, July 19, 2019APPLICATION FILING RECEIPT MAILED
Wednesday, July 24, 2019NON-FINAL ACTION WRITTEN
Thursday, July 25, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, August 20, 2019REFUSAL PROCESSED BY MPU
Tuesday, August 20, 2019NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, September 3, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, September 6, 2019REFUSAL PROCESSED BY IB
Saturday, September 7, 2019ASSIGNED TO LIE
Saturday, September 7, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, September 7, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 12, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 25, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, September 25, 2019NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, September 25, 2019NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Saturday, October 12, 2019NOTIFICATION PROCESSED BY IB
Tuesday, October 15, 2019PUBLISHED FOR OPPOSITION
Tuesday, October 15, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 31, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, March 31, 2020FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, April 17, 2020FINAL DISPOSITION PROCESSED
Friday, April 17, 2020FINAL DISPOSITION NOTICE SENT TO IB
Friday, May 8, 2020FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, August 6, 2021CHANGE OF NAME/ADDRESS REC'D FROM IB
Sunday, November 21, 2021NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, December 31, 2024COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Monday, December 29, 2025TEAS SECTION 71 RECEIVED
Monday, April 20, 2026CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, April 24, 2026REGISTERED-SEC.71 ACCEPTED
Friday, April 24, 2026NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

Related Keywords

alhemo haemostasis preparations pharmaceutical